AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer.
Bardia A, Chandarlapaty S, Linden HM, Ulaner GA, Gosselin A, Cartot-Cotton S, Cohen P, Doroumian S, Paux G, Celanovic M, Pelekanou V, Ming JE, Ternès N, Bouaboula M, Lee JS, Bauchet AL, Campone M.
Bardia A, et al.
Nat Commun. 2022 Jul 15;13(1):4116. doi: 10.1038/s41467-022-31668-8.
Nat Commun. 2022.
PMID: 35840573
Free PMC article.
Clinical Trial.